Controlling spending for prescription drugs

被引：21

作者：

Altman, SH ^{[1
]}

Parks-Thomas, C ^{[1
]}

机构：

[1] Brandeis Univ, Waltham, MA 02254 USA

来源：

关键词：

D O I：

10.1056/NEJM200203143461113

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：855 / 856

页数：3

共 7 条

[1] *CTR MED MED SERV, 2001, NAT HLTH EXP PROJ 20
[2] Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries
Lewis, JH
Schonlau, M
Muñoz, JA
Asch, SM
Rosen, MR
Yang, H
Escarce, JJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11) : 830 - 835
[3] Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors
Schneeweiss, S
Walker, AM
Glynn, RJ
Maclure, M
Dormuth, C
Soumerai, SB
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (11) : 822 - 829
[4] STUART B, 2000, PRESCRIPTION DRUGS C
[5] Growth in prescription drug spending among insured elders
Thomas, CP
Ritter, G
Wallack, SS
[J]. HEALTH AFFAIRS, 2001, 20 (05) : 265 - 277
[6] WALLACK SS, 2001, RECENT TRENDS PRESCR
[7] Zhan Chunliu, 2001, JAMA (Journal of the American Medical Association), V286, P2823